Topical composition comprising saccharide isomerate for microbiome balancing
Summary
The European Patent Office published Unilever's patent application EP3849509A1 for a topical composition comprising saccharide isomerate for microbiome balancing. The patent covers cosmetic formulations using saccharide isomerate (A61K 8/60) for skin microbiome applications, filed by inventors from Unilever IP Holdings B.V. and Unilever Global IP Limited.
What changed
The EPO published patent application EP3849509A1 on March 25, 2026, covering a topical composition comprising saccharide isomerate for balancing the skin microbiome. The patent names Shanthi Appavoo, Anindya Dasgupta, Jessica Krisak, Srikala Kumaran, and Vivek Subramanian as inventors and classifies under A61K 8/60, A61K 8/73, A61Q 17/00, and A61Q 19/00.\n\nThis publication constitutes informational intellectual property documentation under the European Patent Convention. No compliance deadlines, required actions, or penalties are associated with this document. Regulated entities may reference this patent for freedom-to-operate assessments or competitive intelligence purposes.
Source document (simplified)
A TOPICAL COMPOSITION COMPRISING SACCHARIDE ISOMERATE FOR MICROBIOME BALANCING
Publication EP3849509A1 Kind: A1 Mar 25, 2026
Applicants
Unilever IP Holdings B.V., UNILEVER GLOBAL IP LIMITED
Inventors
APPAVOO, Shanthi, DASGUPTA, Anindya, KRISIAK, Jessica, Ann, KUMARAN, Srikala, SUBRAMANIAN, Vivek
IPC Classifications
A61K 8/60 20060101AFI20200321BHEP A61K 8/73 20060101ALI20200321BHEP A61Q 17/00 20060101ALI20200321BHEP A61Q 19/00 20060101ALI20200321BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.